Concepedia

Mary Mac Partlin

MM

3

Publications

202

Citations

3

H-Index

2003

Active since

Affiliations

Oregon Health & Science University(Current)

Mary Mac Partlin is an author at Oregon Health & Science University specializing in cell biology, medicine, and tumor biology.

Top concepts

Publications per year

2003–2015

3

Publications

3

The ABL Switch Control Inhibitor DCC-2036 Is Active against the Chronic Myeloid Leukemia Mutant BCR-ABLT315I and Exhibits a Narrow Resistance Profile

Christopher A. Eide, Lauren T. Adrian, Jeffrey Tyner et al. · Cancer Research · 2011 · 118 citations · Full text

β-Catenin is required for intrinsic but not extrinsic BCR-ABL1 kinase-independent resistance to tyrosine kinase inhibitors in chronic myeloid leukemia

Anna M. Eiring, Jamshid S. Khorashad, David Anderson et al. · Leukemia · 2015 · 42 citations · Full text

, , +6

Interactions of the DNA mismatch repair proteins MLH1 and MSH2 with c-MYC and MAX

Mary Mac Partlin, Elizabeth Homer, Helen M.R. Robinson et al. · Oncogene · 2003 · 42 citations · Full text

, , +8

Rows per page

1–3 of 3